The North America apheresis equipment market is expected to reach US$ 1,387.38 Mn in 2027 from US$ 755.36 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.
The growth of the market is driven by the factors such as, increasing elderly population and increasing incidence of hematologic diseases. However, the market is likely to slower down its growth due to the complications associated with apheresis.
The growing elderly population is the major cause of blood diseases. Aging is a complex process influenced by genetic variables as well as environmental factors. The general aging factors lead to stiffening the heart and blood vessels that lead to heart disorders. Thus, the people with the age of 75 years and above high blood pressure is the common risk factor for the hematological diseases including blood-associated cancer. Management of hematologic disorders in older patients must often be weighed in a setting of decreased physiological reserves and concurrent illnesses.
According to the United Nations World Population Ageing 2017 report, there were 962 million people across the world who were aged 60 years or over and the number is expected to reach nearly 2.1 billion by 2050. In addition, according to the US Census Bureau, the number of Americans above the age of 65 and older is anticipated to grow more than double from 46 million in 2016 to above 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24% from 15 percent. Thus, the rising geriatric population in the region is likely to grow the apheresis equipment market in the forecast period.
US is expected to lead the market in the North America region owing to a rising number of apheresis procedures & their advancements, rising numbers of apheresis centers, and access to the well-developed infrastructure and others. Therefore, considering the above-mentioned factors the growth of the market in the country is likely to contribute the largest share in the North America region during the forecast period.
Mexico Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA APHERESIS EQUIPMENT – MARKET SEGMENTATION
By Product
- Apheresis Machine
- Disposable Apheresis Kits
By Technology
- Membrane Separation
- Centrifugation
By Procedure
- Erythrocytapheresis
- LDL-Apheresis
- Leukapheresis
- Photopheresis
- Plasmapheresis
- Plateletpheresis
By Therapeutic Area
- Renal Diseases
- Haematology
- Neurology
- Other Applications
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Blood Donation Centers
By Geography
North America
- US
- Canada
- Mexico
Company Profiles
- Medica SPA
- Terumo Corporation
- B. Braun Melsungen AG
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- Haemonetics Corporation
- HemaCare Corporation
- KANEKA MEDIX CORPORATION
- Kawasumi Laboratories, Inc.
- medicap clinic GmbH
North America Apheresis Equipment Report Scope
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 755.36 Million |
Market Size by 2027 | US$ 1,387.38 Million |
Global CAGR (2019 - 2027) | 7.3% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Technology, Procedure, Therapeutic Area, End User, and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies in North America Apheresis Equipment Market
- Medica SPA
- Terumo Corporation
- B. Braun Melsungen AG
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- Haemonetics Corporation
- HemaCare Corporation
- KANEKA MEDIX CORPORATION
- Kawasumi Laboratories, Inc.
- medicap clinic GmbH